CONFLUENT INC-CLASS A (CFLT)

US20717M1036 - Common Stock

29.83  +0.57 (+1.95%)

After market: 29.7834 -0.05 (-0.16%)

Fundamental Rating

4

CFLT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. The financial health of CFLT is average, but there are quite some concerns on its profitability. CFLT is valued quite expensively, but it does show have an excellent growth rating.



1

1. Profitability

1.1 Basic Checks

CFLT had positive earnings in the past year.
In the past year CFLT had a positive cash flow from operations.
In the past 5 years CFLT always reported negative net income.
CFLT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of CFLT (-13.46%) is worse than 64.84% of its industry peers.
Looking at the Return On Equity, with a value of -37.58%, CFLT is doing worse than 64.10% of the companies in the same industry.
Industry RankSector Rank
ROA -13.46%
ROE -37.58%
ROIC N/A
ROA(3y)-17.31%
ROA(5y)-28.33%
ROE(3y)-51.25%
ROE(5y)-73.21%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CFLT's Gross Margin of 73.03% is in line compared to the rest of the industry. CFLT outperforms 59.71% of its industry peers.
CFLT's Gross Margin has been stable in the last couple of years.
CFLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.14%
GM growth 5Y-1.21%

5

2. Health

2.1 Basic Checks

CFLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CFLT has been increased compared to 1 year ago.
The debt/assets ratio for CFLT has been reduced compared to a year ago.

2.2 Solvency

CFLT has an Altman-Z score of 3.06. This indicates that CFLT is financially healthy and has little risk of bankruptcy at the moment.
CFLT's Altman-Z score of 3.06 is in line compared to the rest of the industry. CFLT outperforms 49.82% of its industry peers.
CFLT has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.17, CFLT is doing worse than 78.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Altman-Z 3.06
ROIC/WACCN/A
WACC11.32%

2.3 Liquidity

A Current Ratio of 4.24 indicates that CFLT has no problem at all paying its short term obligations.
CFLT has a Current ratio of 4.24. This is amongst the best in the industry. CFLT outperforms 84.62% of its industry peers.
A Quick Ratio of 4.24 indicates that CFLT has no problem at all paying its short term obligations.
CFLT has a better Quick ratio (4.24) than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 4.24
Quick Ratio 4.24

8

3. Growth

3.1 Past

CFLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 287.50%, which is quite impressive.
CFLT shows a strong growth in Revenue. In the last year, the Revenue has grown by 25.00%.
The Revenue has been growing by 64.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)287.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)25%
Revenue growth 3Y48.64%
Revenue growth 5Y64.15%
Sales Q2Q%24.99%

3.2 Future

The Earnings Per Share is expected to grow by 128.01% on average over the next years. This is a very strong growth
CFLT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.64% yearly.
EPS Next Y1217.13%
EPS Next 2Y320.11%
EPS Next 3Y194.87%
EPS Next 5Y128.01%
Revenue Next Year24.71%
Revenue Next 2Y23.02%
Revenue Next 3Y22.53%
Revenue Next 5Y21.64%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 99.43, which means the current valuation is very expensive for CFLT.
CFLT's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.40, CFLT is valued quite expensively.
With a Price/Forward Earnings ratio of 84.51, CFLT can be considered very expensive at the moment.
CFLT's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CFLT to the average of the S&P500 Index (23.67), we can say CFLT is valued expensively.
Industry RankSector Rank
PE 99.43
Fwd PE 84.51

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CFLT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CFLT's earnings are expected to grow with 194.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y320.11%
EPS Next 3Y194.87%

0

5. Dividend

5.1 Amount

No dividends for CFLT!.
Industry RankSector Rank
Dividend Yield N/A

CONFLUENT INC-CLASS A

NASDAQ:CFLT (1/6/2025, 6:20:28 PM)

After market: 29.7834 -0.05 (-0.16%)

29.83

+0.57 (+1.95%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners93.76%
Inst Owner Change0%
Ins Owners3.72%
Ins Owner Change-3.1%
Market Cap9.78B
Analysts78.46
Price Target33.18 (11.23%)
Short Float %5.58%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.97%
Min EPS beat(2)26.5%
Max EPS beat(2)91.45%
EPS beat(4)4
Avg EPS beat(4)86.71%
Min EPS beat(4)26.5%
Max EPS beat(4)152.55%
EPS beat(8)8
Avg EPS beat(8)140.58%
EPS beat(12)12
Avg EPS beat(12)99.59%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.19%
Min Revenue beat(2)0.18%
Max Revenue beat(2)0.2%
Revenue beat(4)4
Avg Revenue beat(4)0.65%
Min Revenue beat(4)0.18%
Max Revenue beat(4)1.83%
Revenue beat(8)8
Avg Revenue beat(8)0.93%
Revenue beat(12)12
Avg Revenue beat(12)2.09%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.19%
PT rev (3m)9.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.85%
EPS NY rev (1m)0%
EPS NY rev (3m)23.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 99.43
Fwd PE 84.51
P/S 10.69
P/FCF N/A
P/OCF 933.4
P/B 10.47
P/tB 12.85
EV/EBITDA N/A
EPS(TTM)0.3
EY1.01%
EPS(NY)0.35
Fwd EY1.18%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.03
OCFY0.11%
SpS2.79
BVpS2.85
TBVpS2.32
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.46%
ROE -37.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.03%
FCFM N/A
ROA(3y)-17.31%
ROA(5y)-28.33%
ROE(3y)-51.25%
ROE(5y)-73.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.14%
GM growth 5Y-1.21%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 117.83%
Cap/Sales 2.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.24
Quick Ratio 4.24
Altman-Z 3.06
F-Score6
WACC11.32%
ROIC/WACCN/A
Cap/Depr(3y)194.9%
Cap/Depr(5y)225.01%
Cap/Sales(3y)2.48%
Cap/Sales(5y)2.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)287.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next Y1217.13%
EPS Next 2Y320.11%
EPS Next 3Y194.87%
EPS Next 5Y128.01%
Revenue 1Y (TTM)25%
Revenue growth 3Y48.64%
Revenue growth 5Y64.15%
Sales Q2Q%24.99%
Revenue Next Year24.71%
Revenue Next 2Y23.02%
Revenue Next 3Y22.53%
Revenue Next 5Y21.64%
EBIT growth 1Y16.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.01%
EBIT Next 3Y66.24%
EBIT Next 5YN/A
FCF growth 1Y92.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.8%
OCF growth 3YN/A
OCF growth 5YN/A